Immuron Limited (IMRN)
NASDAQ: IMRN · IEX Real-Time Price · USD
2.390
+0.130 (5.75%)
At close: Jul 26, 2024, 2:52 PM
2.400
+0.010 (0.42%)
After-hours: Jul 26, 2024, 4:59 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $14.67 million as of July 26, 2024. Its market cap has increased by 27.56% in one year.
Market Cap
14.67M
Enterprise Value
3.92M
1-Year Change
27.56%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $14.67M, a decrease of -47.80%. That is a compound annual growth rate of -8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 13.00M | 21.50% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 14.95M |
| China Jo-Jo Drugstores | 14.84M |
| Flora Growth | 14.84M |
| QT Imaging Holdings | 14.79M |
| CareMax | 14.76M |
| Talphera | 14.53M |
| Alterity Therapeutics | 14.14M |
| BriaCell Therapeutics | 13.99M |